RecruitingNCT04687865

Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection)

Biological Material Bank for Studies Related to Organ Transplantation

Sponsor

Hospices Civils de Lyon

Enrollment

4,000 participants

Start Date

Jan 8, 2020

Study Type

OBSERVATIONAL

Conditions

Organ Transplantation

Summary

This study aims to constitute a collection of biological materials from in transplant patients and to provide biological materials from transplanted patients in order : i) validate new theory on the cause of allograft loss, ii) develop innovative biomarker for rejection and other transplantation-related conditions (such as BK virus nephropathy, Post-transplant lymphoproliferative disorder ( PTLD) ...)

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a biobank study based in Lyon, France, where researchers are collecting blood and tissue samples from organ transplant recipients over time. The goal is to better understand transplant rejection and improve future treatments by studying biological samples. **You may be eligible if...** - You are 18 or older - You have received an organ transplant - You are willing to provide written informed consent **You may NOT be eligible if...** - You are not enrolled in the French social security system - You are incarcerated - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Print for Your Doctor Check Your Eligibility

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiobank

For each patient included in the study the following samples will be collected at the indicated time points after transplantation: * Serum samples and plasma sample: Day1, Month 1, Month 3, Month 6, Month 12, month 60, month 120 and at the time of each allograft biopsy. * Urines samples: Month 3 and Month 12 and at the time of each allograft biopsy. * Peripheral Blood Mononuclear Cell (PBMC): for each organ allograft biopsy. * Allograft biopsies: systematically at Month 3, and Month 12, and for cause in case of allograft dysfunction.

Locations(1)

Hopital Edouard Herriot

Lyon, Rhône, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04687865

Related Trials

Survey on the Evaluation of Medication Information Leaflets for Organ Transplant Patients

NCT066529191 location

Leuven Tolerogenic Protocol for Intestinal Transplantation

NCT023149491 location